Flex Pharma (FLKS) Tops Q4 EPS by 18c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- L3Harris CEO steps down amid conduct review, shares drop
- Oil settles up over $2 as Iran war stalemate stokes supply concerns
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
Flex Pharma (FLKS) PT Lowered to $9 at Jefferies Following 4Q
March 9, 2017 7:37 AM ESTJefferies lowered its price target on Flex Pharma (NASDAQ: FLKS) to $9.00 (from $11.00) while maintaining a Buy rating. FLKS reported EPS and HotShot sales of -$0.48 vs. -$0.62 estimate and $0.3M vs. $0.2M, respectively, with slightly lower opex of $8.3M vs. $10.6M... More
